Mark Mincy on LinkedIn

The pharmacy benefit industry is filled with conflicts of interest that results in over… · Experience: US-RX Care · Location: Orlando · 500+ connections on ...

Mark Mincy - Consultant - GiANT Worldwide - LinkedIn

Gospel Grace. Vocational Joy. Relational Peace. · Prior to making the transition into the consulting and non-profit/ministry sectors, I was privileged to ...

Mark Mincy - Senior Business Development Manager - LinkedIn

Provide Solutions for Architectural, Engineering & Construction Markets · Experienced Senior Account Manager with a demonstrated history of working in the ...

4 "Mark Mincy" profiles - LinkedIn

View the profiles of professionals named "Mark Mincy" on LinkedIn. There are 4 professionals named "Mark Mincy", who use LinkedIn to exchange information, ...

Mark Mincy on LinkedIn: #ceo #coo #cfo #chro #fiduciary #caa ...

Employers, what are you doing to ensure CAA compliance and reduce your risk of litigation? A great start is hiring a "non-conflicted" ...

Mark Mincy on LinkedIn: #ceo #coo #cfo #chro #fiduciary ...

Employers, hopefully you either watched or have read about the Ozempic senate hearing. The issue was why is the price in the United States ...

Mark Mincy on LinkedIn: #ceo #coo #cfo #chro #fiduciary #caa ...

Employers, I wanted to continue to alert you to the primary issues from the recent litigation cases due to overpayments by the employer and ...

Mark Mincy on LinkedIn: #ceo #coo #chro #cfo #fiduciary #caa ...

Mark Mincy's Post ... As the cost of providing health insurance coverage is set to spike 9% in 2025 – higher than this year's 6.3% – employers are ...

Mark Mincy on LinkedIn: Employers, looking to being better informed ...

Employers, looking to being better informed? Please register for this webinar with Antonio. There is a "LOT" going on in the PBM and PhRMA ...

Mark Mincy on LinkedIn: Employers, hope to see you there. Please ...

Mark Mincy's Post. View profile for Mark Mincy, graphic · Mark Mincy. Providing Fiduciary Pharmacy Risk Management Services without changing ...

Mark Mincy on LinkedIn: The Powerful Companies Driving Local ...

Employers, please act to stop this!!! Please realize, you are not getting the benefit of your PBM's underpayments to these pharmacies!

Mark Mincy - 2024 National Alliance PBM Hub - LinkedIn

For decades, the PBM industry has been plagued by misalignment, opacity, and consolidation. The situation has only worsened in recent years ...

Mark Mincy on LinkedIn: PBMs' Backroom Negotiations Revealed in ...

Employers, please read this!!! As I have previously stated, the Big PBMs receive 30+% "class of trade" payments (in addition to rebates) ...

Mark Mincy on LinkedIn: #ceo #cfo #coo #chro #caa #fiduciary ...

5 Key Take-Aways from the FTC and House Oversight Committee PBM Reports 1. Profits are Primary Focus – “PBMs inflate prescription drug costs ...

Mark Mincy on LinkedIn: #ceo #cfo #coo #chro #fiduciary #caa ...

Employers, please note the recent House Oversight Committee PBM report that referenced the USC 2020 report https://lnkd.in/gJUh-_kZ That ...

Mark Mincy on LinkedIn: Home

Better Outcomes and Lower Cost!!! Our Fiduciary Pharmacy Risk Management services are free of conflicts of interest that drive the current ...

Mark Mincy on LinkedIn: #ceo #coo #cfo #chro #caa #fiduciary ...

Employers, please realize that the higher the rebate guarantees, the higher utilization of high-cost medications resulting in an overall ...

Mark Mincy posted on the topic | LinkedIn

Health Rosetta Brokers, please meet with Eric and Darryl during your conference this week. Being a fiduciary PBM means more than simply having pass-through ...

Mark Mincy on LinkedIn: #ceo #cfo #chro #fiduciary #caa ...

Mark is correct. As well, you are placing your company at risk for CAA violations due to the conflicts of interest inherent with your PBM.

Mark Mincy on LinkedIn: #ceo #cfo #chro #fiduciary #caa ...

Please read this! As indicated in previous posts, it is important to realize that your PBM is receiving "Class of Trade" financial incentives from PhRMA to…